Pharmacodynamics of mycophenolic acid in heart allograft recipients: Correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology

Transplantation

Volumn 70, Issue 7, 2000, Pages 1038-1049

  Gummert, Jan F ^a   Barten, Markus J ^a   Van Gelder, Teun ^a   Billingham, Margaret E ^a   Morris, Randall E ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; CONCANAMYCIN A; CYCLINE; DNA; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE ANTIGEN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MECHANISM; FLOW CYTOMETRY; GRAFT REJECTION; HEART TRANSPLANTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0034667746     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200010150-00009     Document Type: Article

References (37)

1. Pharmacodynamic monitoring of cyclosporin
2. Pharmacodynamic monitoring of immunosuppressive drugs
3. Pharmacodynamic monitoring of immunosuppressive drugs
4. What is the dose-response curve for the effects of cyclosporine on calcineurin and cytokine induction in vivo?
5. Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A
6. Pharmacodynamic monitoring of mycophenolic acid in rabbit heterotopic heart transplant model
7. Mechanism of action of mycophenolate mofetil
8. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model
9. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients
10. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients
11. Whole-blood lymphocyte cultures
12. Novel method for the measurement of cytokine production by a one-stage procedure
13. Whole blood culture for measuring mitogen induced T cell proliferation provides superior correlations with disease state and T cell phenotype in asymptomatic HIV-infected subjects
14. Whole-blood culture technique for functional studies of lymphocyte reactivity to mitogens, antigens, and homologous lymphocytes
15. Optimizing whole blood lymphocyte proliferation in the rat
16. Single- and multiple-dose pharmacokinetics and pharmacodynamics of leflunomide's active metabolite A77 1726 in normal Lewis rats
17. Pharmacodynamic modeling of lymphocytopenia and whole blood lymphocyte cultures in prednisolone-treated individuals
18. Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production
19. Cyclin: A nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells
20. The IL-2/IL-2 receptor system: A current overview
21. Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease
22. Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts
23. Effect of anesthesia on a whole blood lymphocyte proliferation assay in the rat
24. Improved technique of heart transplantation in rats
25. Comparison of whole blood and purified canine lymphocytes in a lymphocyte-stimulation microassay
26. Sequential monitoring of peripheral blood lymphocyte subsets in rats
27. A high-performance liquid chromatographic assay with a simple extraction procedure for sensitive quantification of mycophenolic acid in rat and human plasma
28. Prolongation of rat heart allograft survival by RS-61443
29. New immunosuppressive drugs
30. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients
31. A randomised, double-blind, plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation
32. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity
33. Pharmacodynamic assessment of mycophenolic acid in a canine model
34. Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures
35. Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients
36. The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels